APA (7th ed.) Citation

Gudbjornsson B, Geirsson AJ, & Krogh NS. (2018). Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: Results from the nationwide Icelandic ICEBIO registry. Dove Medical Press.

Chicago Style (17th ed.) Citation

Gudbjornsson B, Geirsson AJ, and Krogh NS. Low Starting Dosage of Infliximab with Possible Escalating Dosage in Psoriatic Arthritis Gives the Same Treatment Results as Standard Dosage of Adalimumab or Etanercept: Results from the Nationwide Icelandic ICEBIO Registry. Dove Medical Press, 2018.

MLA (9th ed.) Citation

Gudbjornsson B, et al. Low Starting Dosage of Infliximab with Possible Escalating Dosage in Psoriatic Arthritis Gives the Same Treatment Results as Standard Dosage of Adalimumab or Etanercept: Results from the Nationwide Icelandic ICEBIO Registry. Dove Medical Press, 2018.